Isis Pharmaceuticals 4Q loss widens on costs
March 6, 2010 by biotechconnection.com · Leave a Comment
Isis Pharmaceuticals 4Q loss widens on costs
Biotechnology company Isis Pharmaceuticals Inc. said Monday its fourth-quarter loss widened on a boost in research and development costs.
Read more on Seattle Times